Johnson & Johnson Receives Subpoenas Over Talc Safety Information

Pharmaceutical giant Johnson & Johnson has received subpoenas from the Securities and Exchange Commission as well as the Department of Justice over the safe of its baby powder and talc products.

Johnson & Johnson has faced many allegations and lawsuits over its baby powder and talc products contributing to causing cancer.

News of the subpoenas was released in the company’s annual federal report filed with the SEC and Johnson & Johnson has said that it will comply with the subpoenas.

It was in January that the company reported fourth quarter financial results that were better than expected. The company also projected a modest increase for full year sales for 2019.

It was in December that shares had collapsed to see the biggest loss in over fifteen years after a report said that Johnson & Johnson had known about its raw talc and finished powder testing positive for trades of asbestos. Asbestos is a carcinogen that has been linked to cancer

At the time, the company said in an email to TheStreet, “The Reuters article is one-sided, false and inflammatory. Simply put, the Reuters story is an absurd conspiracy theory, in that it apparently has spanned over 40 years, orchestrated among generations of global regulators, the world’s foremost scientists and universities, leading independent labs, and J&J employees themselves.”

“Johnson & Johnson’s baby powder is safe and asbestos-free. Studies of more than 100,000 men and women show that talc does not cause cancer or asbestos-related disease,” the statement added. “Thousands of independent tests by regulators and the world’s leading labs prove our baby powder has never contained asbestos.”

Disclaimer: We have no position in Johnson & Johnson (NYSE: JNJ) and have not been compensated for this article.